Drug Type CAR-T |
Synonyms- |
Target |
Mechanism DR5 inhibitors(Tumor necrosis factor receptor superfamily member 10B inhibitors), Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Liver Cancer | Phase 2 | CN | 26 Apr 2019 |